Home
ICUCW
ICUCW News

Latest SeaStar Medical Holding Corporation Warrant (ICUCW) News on May 16, 2025

GuruFocus.com

17 hours ago

SeaStar Medical Holding Corp (ICU) Q1 2025 Earnings Call Highlights: Revenue Surge and ...

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire

a day ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

GlobeNewswire

3 days ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

GlobeNewswire

8 days ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

GlobeNewswire

16 days ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

GlobeNewswire

a month ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Thomson Reuters StreetEvents

2 months ago

Q4 2024 SeaStar Medical Holding Corp Earnings Call

GuruFocus.com

2 months ago

SeaStar Medical Holding Corp (ICU) Q4 2024 Earnings Call Highlights: Strategic Advances Amidst ...

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire

2 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

GlobeNewswire

2 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

PR Newswire

2 months ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

3 months ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

3 months ago

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

GlobeNewswire

4 months ago

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

Mayo Clinic joins SeaStar Medical for acute kidney injury trial

Medical Device Network

4 months ago

Mayo Clinic joins SeaStar Medical for acute kidney injury trial

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

GlobeNewswire

4 months ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical says FDA approves feasibility study with SCD-ADULT

TipRanks

4 months ago

SeaStar Medical says FDA approves feasibility study with SCD-ADULT

MT Newswires

4 months ago

SeaStar Medical Says FDA Approved Study on Selective Cytopheretic Device in Cardiorenal Syndrome

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

GlobeNewswire

4 months ago

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

GlobeNewswire

4 months ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

GlobeNewswire

5 months ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

GlobeNewswire

5 months ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

GlobeNewswire

5 months ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

GlobeNewswire

5 months ago

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

GlobeNewswire

6 months ago

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

GlobeNewswire

6 months ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

GlobeNewswire

6 months ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

6 months ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

GlobeNewswire

6 months ago

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

GlobeNewswire

6 months ago

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

GlobeNewswire

7 months ago

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

GlobeNewswire

7 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

GlobeNewswire

7 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

GlobeNewswire

7 months ago

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

GlobeNewswire

7 months ago

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

Medical Device Network

7 months ago

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

GlobeNewswire

7 months ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

GlobeNewswire

7 months ago

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

7 months ago

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

GlobeNewswire

7 months ago

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

GlobeNewswire

8 months ago

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

GlobeNewswire

8 months ago

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

GlobeNewswire

8 months ago

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

MT Newswires

9 months ago

Top Premarket Decliners

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

9 months ago

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

GlobeNewswire

10 months ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

MT Newswires

10 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires

10 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

10 months ago

SeaStar Medical Treats First Pediatric Patient in Commercial Setting With Kidney Drug

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device

GlobeNewswire

10 months ago

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

GlobeNewswire

10 months ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

GlobeNewswire

10 months ago

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

MT Newswires

10 months ago

Sector Update: Health Care

MT Newswires

10 months ago

SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

GlobeNewswire

10 months ago

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

10 months ago

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MT Newswires

10 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

10 months ago

SeaStar Medical Launching $10 Million Direct Offering -- Shares Fall

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

10 months ago

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MT Newswires

10 months ago

SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

GlobeNewswire

10 months ago

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

GlobeNewswire

a year ago

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

GlobeNewswire

a year ago

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

GlobeNewswire

a year ago

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

GlobeNewswire

a year ago

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

SeaStar Medical Announces 25-for-1 Reverse Stock Split

GlobeNewswire

a year ago

SeaStar Medical Announces 25-for-1 Reverse Stock Split

Seastar touts positive case studies for selective cytopheretic device

Medical Device Network

a year ago

Seastar touts positive case studies for selective cytopheretic device

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

GlobeNewswire

a year ago

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

GlobeNewswire

a year ago

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire

a year ago

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

GlobeNewswire

a year ago

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

GlobeNewswire

a year ago

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

GlobeNewswire

a year ago

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

Thomson Reuters StreetEvents

a year ago

Q4 2023 Nuwellis Inc Earnings Call

Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure

GlobeNewswire

a year ago

Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

GlobeNewswire

a year ago

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury

GlobeNewswire

a year ago

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury

Unleash Massive Returns With These 3 Top Penny Stocks

InvestorPlace

a year ago

Unleash Massive Returns With These 3 Top Penny Stocks

Google starts a limited test of generative AI tools in Maps

Engadget

a year ago

Google starts a limited test of generative AI tools in Maps

Dave Ramsey: 10 Genius Things To Do With Your Money

GOBankingRates

a year ago

Dave Ramsey: 10 Genius Things To Do With Your Money

Esker Named in First-Ever Gartner® Magic Quadrant™ for Source-to-Pay Suites

Business Wire

a year ago

Esker Named in First-Ever Gartner® Magic Quadrant™ for Source-to-Pay Suites

Traefik Labs Appoints Sudeep Goswami as CEO, Founder Emile Vauge Transitions to Chief Technology Officer

Business Wire

a year ago

Traefik Labs Appoints Sudeep Goswami as CEO, Founder Emile Vauge Transitions to Chief Technology Officer

Chapel Hart Kicks Off Ford Truck Month with "This Girl Likes Fords"

Business Wire

a year ago

Chapel Hart Kicks Off Ford Truck Month with "This Girl Likes Fords"

Airspace Link FAA-Approved to Provide B4UFLY Services: Streamlining the Safe Integration of Drones into the National Airspace

PR Newswire

a year ago

Airspace Link FAA-Approved to Provide B4UFLY Services: Streamlining the Safe Integration of Drones into the National Airspace

SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology

GlobeNewswire

a year ago

SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology

Girona take Liga lead back with win at Celta

AFP

a year ago

Girona take Liga lead back with win at Celta

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

a year ago

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market

Reuters

a year ago

UPDATE 1-Brazil's Lula slams miner Vale over 2019 Brumadinho disaster

GlobeNewswire

a year ago

Optical Brighteners Market to Hit US$ 2,656.2 Million by 2033 | Updated Insights Report by Persistence Market Research

GlobeNewswire

a year ago

Irradiation Sterilization Services Market anticipated to grow at CAGR of 9.2% by 2030, According to Persistence Market Research

Q-Gold Comments on Trading Activity at Request of the Canadian Investment Regulatory Organization (“CIRO”)

GlobeNewswire

a year ago

Q-Gold Comments on Trading Activity at Request of the Canadian Investment Regulatory Organization (“CIRO”)

GlobeNewswire

a year ago

Viscosupplementation Market Predicted to Hit US$ 13.6 Billion in 2032, Riding on a Strong 10.8% CAGR | According to Persistence Market Research

Star Equity Holdings Announces $5.9 Million Sale-Leaseback Transaction

GlobeNewswire

a year ago

Star Equity Holdings Announces $5.9 Million Sale-Leaseback Transaction

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

GlobeNewswire

a year ago

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Business Wire

a year ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure

GlobeNewswire

a year ago

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure

Share on Social Networks: